Cytosystems Invited to MEDICA Trade Fair
Cytosystems has been invited to attend the MEDICA trade fair brokerage and pitching events in Dusseldorf 13th-16th November through their involvement in the EU Horizon 2020 scheme. The €3.2million grant which was awarded in 2015 has allowed the company to continue in their development of bladder cancer diagnostics and look towards a full clinical trial of their first product BladderLight™.
To coincide with their attendance at the trade fair, a new brochure presented by Cytosystems describes, for the first time, their technology solution for bladder cancer stratification through their product BladderLight™. BladderLight™, an integrated and automated digital pathology solution for the diagnosis and monitoring of bladder cancer, marks a step-change in non-invasive bladder cancer diagnostics.
Comprising of three component technologies, BladderLight™ provides superior accuracy by optimising each step in the diagnostic workflow, mitigating the current limitations of urine cytology and biomarker analysis.